Ah Ruem Baek

Title: Ah Ruem Baek: Innovations in Biomedical Research

Introduction

Ah Ruem Baek is an inventor based in Daejeon, South Korea, whose work spans biomedical research and molecular diagnostics. His listed inventions include 2 patents, and he is associated with Konkuk University.

Latest Patents

One of Baek’s patents concerns a pharmaceutical composition containing a keratin 8 phosphorylation inhibitor for preventing or treating macular degeneration. The invention describes trametinib or gefitinib as potential components and presents a screening method for identifying macular degeneration treatments. According to the patent description, the composition may affect keratin 8 phosphorylation and organization in retinal pigment epithelial cells under oxidative stress, while influencing E-cadherin and vimentin expression.

Another patent covers a PCR composition containing polyethylene glycol-engrafted nanosized graphene oxide, or PEG-nGO. The disclosed composition is intended to improve PCR efficiency and specificity while reducing reaction time, and the patent also describes a PCR method using the material.

Career Highlights

Baek’s listed patent work addresses two distinct technical areas: potential therapeutic approaches to macular degeneration and improvements to PCR. Together, these inventions reflect applications of research in both biomedical treatment and laboratory methods.

Collaborations

Baek’s listed coworkers include Dong Eun Kim and Hyo Ryoung Kim. His company affiliation is Konkuk University.

Conclusion

Ah Ruem Baek’s patent portfolio brings together research on macular degeneration and PCR technology, highlighting his contributions to biomedical innovation.